← back to search

Ho‐Jin Lee

Seoul National University Hospital · US
Area of research
Surgery · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Anesthesia and Pain Management, Nausea and vomiting management, Cardiac, Anesthesia and Surgical Outcomes, and Enhanced Recovery After Surgery.
h-index
30
citations
3,329
works
227
NIH funding
primary concept
email

Recent publications

Dual-channel fluorescent probe for discriminative detection of H2S and N2H4: Exploring sensing mechanism and real-time applications
Journal of Hazardous Materials 2023cited by 67position: middledoi
A coumarin derivative-based turn-on fluorescent probe for real-time applications of hydrazine detection in environment and bioimaging
Dyes and Pigments 2023cited by 36position: middledoi
Trial in progress: A phase 1, first-in-human, open-label, multicenter, dose-escalation and dose-expansion study of ASP3082 in patients with previously treated advanced solid tumors and KRAS G12D mutations.
Journal of Clinical Oncology 2023cited by 32position: middledoi
Quinoline-derived electron-donating/withdrawing fluorophores for hydrazine detection and applications in environment and bioimaging
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy 2023cited by 21position: middledoi
Insights of keratin geometry from agro-industrial wastes: A comparative computational and experimental assessment
Food Chemistry 2023cited by 13position: middledoi
Radiographic progression in the absence of prostate-specific antigen (PSA) progression in patients with metastatic hormone-sensitive prostate cancer (mHSPC): Post hoc analysis of ARCHES.
Journal of Clinical Oncology 2022cited by 24position: middledoi
Efficacy of enzalutamide in subgroups of men with metastatic hormone-sensitive prostate cancer based on prior therapy, disease volume, and risk
Prostate Cancer and Prostatic Diseases 2021cited by 24position: middledoi
Efficacy of Enzalutamide plus Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer by Pattern of Metastatic Spread: ARCHES Post Hoc Analyses
The Journal of Urology 2020cited by 39position: middledoi
Safety and efficacy of depatuxizumab mafodotin + temozolomide in patients with<i>EGFR</i>-amplified, recurrent glioblastoma: results from an international phase I multicenter trial
Neuro-Oncology 2018cited by 97position: middledoi
Efficacy and safety results of depatuxizumab mafodotin (ABT‐414) in patients with advanced solid tumors likely to overexpress epidermal growth factor receptor
Cancer 2018cited by 58position: middledoi
Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international study
Cancer Chemotherapy and Pharmacology 2017cited by 133position: middledoi
Safety, pharmacokinetics, and antitumor response of depatuxizumab mafodotin as monotherapy or in combination with temozolomide in patients with glioblastoma
Neuro-Oncology 2017cited by 76position: middledoi
Conformational change of Dishevelled plays a key regulatory role in the Wnt signaling pathways
eLife 2015cited by 62position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Lisa Roberts Rapp · AbbVie (United States)4 papers (2017–2018)Kyle D. Holen · AbbVie (United States)4 papers (2017–2018) · 4 papers (2023–2023)Peter Ansell · University of Oklahoma Health Sciences Center4 papers (2017–2018)Gabriel P. Haas · Astellas Pharma (United States)3 papers (2020–2022)Jeffrey M. Holzbeierlein · University Hospital and Clinics3 papers (2020–2022)Zarnie Lwin · Cancer Care Services3 papers (2017–2018)Taro Iguchi · Osaka City University3 papers (2020–2022)F. Gómez-Veiga · Instituto de Investigación Biomédica de Salamanca3 papers (2020–2022)Kanagaraj Rajalakshmi · Jiangsu University3 papers (2023–2023)Hui Gan · Southwest Minzu University3 papers (2017–2018)Martin J. van den Bent · St James's University Hospital3 papers (2017–2018)Selvaraj Muthusamy · Virginia Commonwealth University3 papers (2023–2023)Hao Xiong · Guangxi Medical University3 papers (2017–2018)B. Yа. Alekseev · Ministry of Health3 papers (2020–2022)Kyriakos P. Papadopoulos · Texas Center for Infectious Disease3 papers (2017–2018)Dongwei Zhu · Jiangsu University3 papers (2023–2023)Andrew J. Armstrong · Duke University3 papers (2020–2022)Arnauld Villers · Institut Paoli-Calmettes3 papers (2020–2022)Andrew B. Lassman · Columbia University3 papers (2017–2018)